90610-19-8

Basic information

• Product Name: 2-ethyl-5-nitro-anisole
• Synonyms: 2-ethyl-5-nitro-anisole
• CAS NO: 90610-19-8
• Molecular Weight: 181.191
• Mol File: 90610-19-8.mol

Chemical Properties

• CAS DataBase Reference: 2-ethyl-5-nitro-anisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ethyl-5-nitro-anisole(90610-19-8)
• EPA Substance Registry System: 2-ethyl-5-nitro-anisole(90610-19-8)

Safety Data

• Hazardous Substances Data: 90610-19-8(Hazardous Substances Data)

Upstream product

• 90005-90-6 2-ethyl-5-nitro-phenol 
• 74-88-4 methyl iodide 
• 20191-74-6 2-ethyl-5-nitroaniline 

Downstream Products

• 90564-14-0 1-(2-methoxy-4-nitrophenyl)ethanone 
• 947691-59-0 4-ethyl-3-methoxy-benzenamine 
• 100965-09-1 1-(2-benzoyloxy-4-nitro-phenyl)-2-bromo-ethanone 
• 100961-78-2 1-(2-benzoyloxy-4-nitro-phenyl)-ethanone 
• 5230-72-8 2-bromo-1-(2-hydroxy-4-nitro-phenyl)-ethanone 
• 1834-91-9 2-hydroxy-4-nitroacetophenone 

Relevant articles and documents

PHOSPHODIESTERASE 10 INHIBITORS

The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

CINNOLINE AND QUINAZOLINE DERIVATES AS PHOSPHODIESTERASE 10 INHIBITORS

The present invention is directed to cinnoline and quinazoline compounds of formula (I) that are PDE10 inhibitors, pharmaceutical compounds containing the same and processes for preparing the same. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive-compulsive disorder, and the like.